To investigate whether initiation of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with both reduced risks of incident alcohol, cannabis, c…
New and emerging treatments for anxiety disorders.
Anxiety disorders affect a large portion of the population. While standard treatments show efficacy, rates of treatment non-response and relapse highlight th…